title: European regulatory experience with drugs for central nervous system disorders.
authors.affiliation: European Medicines Agency, 30 Churchill Place, Canary Wharf, London E14 5EU, United Kingdom.
authors.forename: Florence
authors.initials: F
authors.lastname: Butlen-Ducuing
authors.affiliation: European Medicines Agency, 30 Churchill Place, Canary Wharf, London E14 5EU, United Kingdom.
authors.forename: Malgorzata
authors.initials: M
authors.lastname: Zienowicz
authors.affiliation: European Medicines Agency, 30 Churchill Place, Canary Wharf, London E14 5EU, United Kingdom.
authors.forename: Frank
authors.initials: F
authors.lastname: Pétavy
authors.affiliation: European Medicines Agency, 30 Churchill Place, Canary Wharf, London E14 5EU, United Kingdom.
authors.forename: Manuel
authors.initials: M
authors.lastname: Haas
authors.affiliation: Medical Products Agency, SE-751 03 Uppsala, Sweden, and is Chair of the CHMP.
authors.forename: Tomas
authors.initials: T
authors.lastname: Salmonson
authors.affiliation: European Medicines Agency, 30 Churchill Place, Canary Wharf, London E14 5EU, United Kingdom.
authors.forename: Hans-Georg
authors.initials: HG
authors.lastname: Eichler
authors.affiliation: European Medicines Agency, 30 Churchill Place, Canary Wharf, London E14 5EU, United Kingdom.
authors.forename: Guido
authors.initials: G
authors.lastname: Rasi
mesh_terms: D002491:Central Nervous System Agents / Q000191:economics / Q000592:standards*; D002493:Central Nervous System Diseases / Q000188:drug therapy*; D017277:Drug Approval / Q000331:legislation & jurisprudence / Q000706:statistics & numerical data; D005060:Europe; D033161:Government Regulation; D006801:Humans; D040541:Marketing / Q000331:legislation & jurisprudence
chemical_list: D002491:Central Nervous System Agents